BRYAN GOURLEY: Open Payments
NPI 1629500947 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,093 in 114 payments from 19 companies in 2025. Trend: 2023 $2,202 · 2024 $4,169 · 2025 $9,093
Speaker / faculty: $5,785Food & beverage: $2,290Travel & lodging: $820Education: $198
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 41 | $7,636 |
| GlaxoSmithKline, LLC. | 23 | $307 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| Actelion Pharmaceuticals US, Inc. | 5 | $144 |
| Phathom Pharmaceuticals, Inc. | 3 | $128 |
| SANOFI-AVENTIS U.S. LLC | 1 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Amgen Inc. | 4 | $71 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| Philips North America LLC | 3 | $57 |
Products named: Prolastin-C Liquid, DUPIXENT, NUCALA, VOQUEZNA, OPSUMIT, TRELEGY ELLIPTA, TEZSPIRE, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
